Related Experiment Video
Updated: May 14, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Functional Assessment of Hypertrophic Phenotype Cardiomyopathies Using Combined Cardiopulmonary Exercise Testing and
Mattia Scolari1, Iacopo Fabiani2, Lorenzo Bazan3
1Health Science Interdisciplinary Center, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy.
Insights
Combined Cardiopulmonary Exercise Testing-Exercise Stress Echocardiography (CPET-ESE) reveals distinct exercise profiles in hypertrophic phenotypes. This integrated approach aids in understanding exertional symptoms beyond resting structural parameters.
Area of Science:
- Cardiology
- Exercise Physiology
- Medical Imaging
Background:
- Resting structural parameters in left ventricular hypertrophy may not fully explain exertional symptoms.
- Integrated functional assessment is needed to characterize hypertrophic phenotypes during exercise.
Purpose of the Study:
- To investigate the utility of combined Cardiopulmonary Exercise Testing-Exercise Stress Echocardiography (CPET-ESE) for functional characterization of hypertrophic phenotypes.
- To differentiate physiological exercise profiles across obstructive hypertrophic cardiomyopathy, transthyretin cardiac amyloidosis, and preserved-ejection-fraction hypertrophic phenotypes.
Main Methods:
- Prospective pilot study involving 43 patients with distinct hypertrophic phenotypes.
- Symptom-limited semi-supine CPET-ESE performed using an individualized ramp protocol.
- Peak effort defined by symptom limitation and respiratory exchange ratio (RER≥1.05); peak VO2 assessed.
Main Results:
- Obstructive hypertrophic cardiomyopathy patients exhibited higher peak VO2 compared to other groups, despite lower chronotropic reserve.
- Preserved-ejection-fraction group showed reduced peripheral oxygen extraction; transthyretin amyloidosis displayed mixed central/peripheral limitation.
- Right ventricle-pulmonary artery uncoupling was noted in transthyretin amyloidosis and preserved-ejection-fraction groups.
Conclusions:
- CPET-ESE may differentiate physiological exercise profiles in hypertrophic phenotypes.
- Findings are exploratory due to small, heterogeneous, single-center cohort.
- Larger validation studies are necessary to confirm mechanistic and predictive conclusions.
Abstract:
Background: In patients with left ventricular hypertrophy, resting structural parameters alone may not explain exertional symptoms. Hence, we investigate whether combined Cardiopulmonary Exercise Testing- Exercise Stress Echocardiography (CPET-ESE) can provide an integrated functional characterisation of hypertrophic phenotypes. Methods: As a preliminary investigation, this prospective single-centre pilot study enrols 43 patients, categorised into: obstructive hypertrophic cardiomyopathy (n = 19), transthyretin cardiac amyloidosis (n = 15), or preserved-ejection-fraction hypertrophic phenotypes (n = 9). Patients undergo symptom-limited semi-supine CPET-ESE on an electronically braked cycle ergometer with an individualised ramp protocol. Peak effort is defined by symptom limitation and respiratory exchange ratio criteria (RER≥1.05), while peak VO2 is defined as the highest 30 s averaged value. Results: Exercise responses differ across phenotypes. Patients with obstructive hypertrophic cardiomyopathy have higher peak VO2 than the other groups, despite their lower chronotropic reserve. The preserved-ejection-fraction hypertrophic group shows lower peripheral oxygen extraction, whereas transthyretin amyloidosis shows a mixed central and peripheral limitation pattern. Right ventricle-pulmonary artery uncoupling is observed in the latter two groups. Conclusions: The use of CPET-ESE may help describe distinct physiological exercise profiles in hypertrophic phenotypes, but these findings should be considered exploratory. The small, heterogeneous and single-centre cohort precludes definitive mechanistic or predictive conclusions and supports the need for larger validation studies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
